| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Physiological Sciences, Eastern Virginia Medical School (M.G.L., G.J.P.), Norfolk, Virginia 23501; and the Departments of Obstetrics/Gynecology/Reproductive Sciences and Physiology, Center for Studies in Reproduction, University of Maryland School of Medicine (E.D.A.), Baltimore, Maryland 21201
Address all correspondence and requests for reprints to: Gerald J. Pepe, Ph.D., Department of Physiological Sciences, Eastern Virginia Medical School, P.O. Box 1980, Norfolk, Virginia 23501-1980. E-mail: gjp{at}borg.evms.edu
Throughout gestation, the primate fetal adrenal gland is comprised of
the fetal zone, which expresses the P-450 17
-hydroxylase-C17,20
lyase (P-450c17) enzyme that catalyzes the synthesis of C19
steroids used for placental estrogen production. The development of the
transitional zone comprised of cortical cells that express the P-450c17
and the 3ß-hydroxysteroid dehydrogenase-isomerase (3ßHSD) enzymes
for cortisol production, and the definitive zone, which expresses
3ßHSD, but not P-450c17, for mineralocorticoid synthesis, does not
occur until relatively late in gestation. Although ACTH is considered
essential to fetal adrenal growth and function, the role that ACTH has
in the development of the transitional and definitive zones, is less
clear. To answer this question, the width of these zones was determined
by immunocytochemical expression of P-450c17 and/or 3ßHSD in fetal
adrenal glands obtained on day 100 (mid) of gestation (term = day
184) from baboons in which ACTH was administered to the fetus on days
9599 of gestation or on day 165 (late) of gestation from baboons in
which fetal ACTH was suppressed by treatment of the mother and fetus
with betamethasone on days 150164 of gestation. At midgestation, the
fetal adrenal was comprised almost exclusively of fetal zone cells and
a small definitive zone (38 ± 2 µm in width), but was
essentially devoid of a transitional zone (7 ± 2 µm). Treatment
with ACTH enhanced (P < 0.05) the width of the
transitional zone (67 ± 4 µm), but not the size of the
definitive zone (10 ± 4 µm). In late gestation, the width of
the definitive zone, although 2-fold greater than that on day 100, was
smaller (P < 0.05) than that of the transitional
zone (120 ± 15 µm), which greatly exceeded that at
midgestation. Treatment with betamethasone in late gestation eliminated
the transitional zone, but had no effect on the size of the definitive
zone (120 ± 8 µm). These findings indicate that the development
of the baboon fetal adrenal transitional zone late in gestation is
dependent on fetal pituitary ACTH. In contrast, the ontogenesis of the
definitive zone at midgestation and its growth in late gestation occur
in the relative absence of ACTH.
This article has been cited by other articles:
![]() |
A. Dumitrescu, G. W Aberdeen, G. J Pepe, and E. D Albrecht Developmental expression of cell cycle regulators in the baboon fetal adrenal gland J. Endocrinol., January 1, 2007; 192(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishimoto, D. G. Ginzinger, T. Matsumoto, Y. Hattori, M. Furuya, K. Minegishi, M. Tanaka, Y. Yoshimura, and R. B. Jaffe Differential Zonal Expression and Adrenocorticotropin Regulation of Secreted Protein Acidic and Rich in Cysteine (SPARC), a Matricellular Protein, in the Midgestation Human Fetal Adrenal Gland: Implications for Adrenal Development J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3208 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishimoto, D. G. Ginzinger, and R. B. Jaffe Adrenocorticotropin Preferentially Up-Regulates Angiopoietin 2 in the Human Fetal Adrenal Gland: Implications for Coordinated Adrenal Organ Growth and Angiogenesis J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1909 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Duffy, C. L. Seachord, and B. L. Dozier Microsomal prostaglandin E synthase-1 (mPGES-1) is the primary form of PGES expressed by the primate periovulatory follicle Hum. Reprod., June 1, 2005; 20(6): 1485 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Albrecht, R. B. Billiar, G. W. Aberdeen, J. S. Babischkin, and G. J. Pepe Expression of Estrogen Receptors {alpha} and {beta} in the Fetal Baboon Testisand Epididymis Biol Reprod, April 1, 2004; 70(4): 1106 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Feltus, W. J. Kovacs, W. Nicholson, C. M. Silva, S. K. Nagdas, N. A. Ducharme, and M. H. Melner Epidermal Growth Factor Increases Cortisol Production and Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase Expression in Human Adrenocortical Carcinoma Cells: Evidence for a Stat5-Dependent Mechanism Endocrinology, May 1, 2003; 144(5): 1847 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mapes, A. F. Tarantal, C. R. Parker, F. M. Moran, J. M. Bahr, L. Pyter, and A. J. Conley Adrenocortical Cytochrome b5 Expression during Fetal Development of the Rhesus Macaque Endocrinology, April 1, 2002; 143(4): 1451 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Breault, E. Chamoux, J.-G. LeHoux, and N. Gallo-Payet Localization of G Protein {{alpha}}-Subunits in the Human Fetal Adrenal Gland Endocrinology, December 1, 2000; 141(12): 4334 - 4341. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |